Shamonda Virus in France: First Human Case Reported

PARIS France has reported the world's first documented human infection with Shamonda virus, an insect-borne pathogen primarily associated with livestock, after a severely immunocompromised patient died in Lyon earlier this month.

The French authorities confirmed the infection on October 22, describing it as an exceptional case involving a patient who was receiving treatment for a serious underlying illness. The circumstances surrounding the infection and the patient's death remain under investigation.

Until this case, Shamonda virus was considered a livestock-associated virus that had not been documented in humans. The discovery has prompted health authorities and scientific agencies to examine its potential to infect people and determine whether the incident has broader public health implications.

French officials have stressed that no identifiable health risk to the general population has been established at this stage. The European Centre for Disease Prevention and Control (ECDC) is monitoring the situation in coordination with French authorities and other European partners.

Shamonda virus belongs to the Orthobunyavirus group and is primarily associated with infections in animals. It is understood to spread through the bites of infected Culicoides biting midges, small insects that transmit several livestock diseases.

The virus was first identified in cattle in Nigeria in 1965 and has subsequently been detected in parts of Africa and Asia, including Japan. Its appearance in European livestock in 2026 has brought renewed attention to its distribution and potential effects.

Cattle are considered the principal animal hosts, although infections have also been reported in sheep, goats, horses and alpacas.

The virus is related to other members of the Simbu group, including Schmallenberg virus, which is associated with reproductive problems in livestock. However, the behaviour and long-term effects of the Shamonda virus variants recently detected in Europe are not yet fully understood.

The first reported human infection is significant because it challenges the previous understanding that the virus did not infect people. Scientists will need further evidence to determine whether this case represents an extremely rare event or indicates a previously unrecognised possibility of human infection.

According to French authorities, the patient had a severely weakened immune system and was being treated for a serious illness at a hospital in Lyon.

The patient died in early October. However, investigations are continuing to establish the circumstances of the infection and clarify the relationship between the virus and the death.

The leading hypothesis is that the infection was acquired through the bite of an infected biting midge in eastern France, where the virus had been circulating among animals during the spring and summer of 2026.

Health authorities are conducting clinical, laboratory and epidemiological investigations to establish how the infection occurred and assess its implications for human health.

The patient's underlying condition is an important consideration. Severe immunodeficiency can make individuals more vulnerable to infections and complications, meaning that this case cannot automatically be treated as representative of the risk to healthy people.

Authorities have not identified evidence of wider human transmission. Nevertheless, further investigation is necessary because the potential for human infection was not previously established.

The human case comes after Shamonda virus was detected in European farm animals for the first time in 2026.

The virus was identified in livestock in Europe during the summer, with reports involving France, Germany and Switzerland among the initial detections. Subsequent surveillance indicated that it had been detected in more than a dozen European countries by October.

In affected animals, reported signs can include fever, diarrhoea, reduced milk production and reproductive complications. These may include abortions and foetal abnormalities. Neurological symptoms have also been reported less frequently in some animals.

The full impact of the virus on European livestock remains uncertain, particularly as researchers assess the variants circulating in the region.

Its spread matters to farmers and the agricultural sector because livestock infections can affect animal health, milk production and breeding outcomes. Monitoring animal infections can also help researchers understand how the virus circulates and whether its behaviour is changing.

The World Organisation for Animal Health has highlighted the importance of surveillance and collaboration between veterinary and public health experts to improve understanding of the virus.

French authorities have notified international health organisations, including the World Health Organization and the ECDC, about the first documented human infection.

The investigation follows a One Health approach, which brings together human health, animal health and environmental expertise to examine infectious disease risks across species.

Researchers will need to establish how the virus infected the patient, assess whether similar infections have gone undetected and improve understanding of its potential to affect humans.

For now, the reported case does not establish that Shamonda virus is spreading between people or that a wider human outbreak is developing. The available evidence remains limited to the exceptional case reported in France.

The immediate priority is to complete the epidemiological investigation, continue surveillance in livestock and monitor for any additional human infections.

Although the discovery marks an important development in understanding Shamonda virus, French authorities maintain that no health risk to the general population has been identified. Further scientific evidence will be needed to determine the significance of this first human case.